Cellular Therapies tissue manipulation and clinical solutions Cell Therapies
 
Cell Therapies delivers flexible solutions across the full spectrum of clinical trials involving cell and tissue manipulation
 
 

Cell Therapies, through the Centre for Blood Cell Therapy combines leading scientists and researchers. Our academic institute brings substantial expertise in fundamental research to any clinical trial, and therefore the potential to add value to research collaborations.
The staff of Cell Therapies |
Fully integrated multi-modality imaging facility and a GMP/TGA licensed facility deliver critical new information about the fate of transplanted cells.
Tracking studies utilizing labelled cells |
Peter Mac was the first cGMP and Therapeutic Goods Administration-accredited laboratory in Australia. The TGA is a unit of the Federal Government which is responsible for administering the provisions of the Australian legislation for blood and related bio-materials.
Peter Mac's CBCT facilities |

The first Therapeutic Goods Administration-accredited laboratory in Australia
cGMP CONTRACT MANUFACTURING
Cell Therapies P/L provides a one-stop shop for organisations seeking cGMP manufacturing and clinical trials expertise. We can work with a wide range of cell types and clinical conditions and we are a fully integrated clinical facility.
CELL THERAPIES FACT FILE
Nine years experience in Advanced Cell Therapies >1,000 Products Processed Annually Multiple International Collaborations Flexible Business Arrangements Fully Integrated Recruitment Systems 24/7 Communications Confidentiality Protocols Five Clean Rooms Advanced Diagnostic Imaging including: PET, SPECT & PET/CT, 3T MRI
EXAMPLES OF CELL THERAPIES CAPABILITIES IN
AUTOLOGOUS & ALLOGENEIC CELL TYPES
Chondrocytes Osteoarthritis
Dendritic CellsMyeloma, Melanoma, HepC, Lung, Breast & Ovarian Cancer
Islets Diabetes
MAK Cellsvarian Cancer
Master Cell Banking N/A
Mononuclear CellsOsteoarthritis
MSC’s Bone Repair, Cardiac Regeneration
HPC-AHaematological Malignancies, Breast Cancer
Peptide Fill N/A
T-CellsAML, MM, MDS
 
 
In association with Peter MacCallum Cancer Research - Genetics, Genomics and Biotechnology BioMelbourne Network - Progressing BioIndustry
Cell Therapies Pty Ltd ABN 100 285 916